Stati Uniti, i medici dell’Ama contro la pubblicità dei farmaci etici

THEThe US government prohibits producers from communicating to the general public on prescription drugs. This is the request launched by the American medical association (the AMA, the main acronym of US doctors with more than 200,000 members) to put a stop to the wild growth in marketing costs incurred by manufacturers. A continuous rise in costs, is the Ama's accusation, which has repercussions on prices to the public and thus excludes a growing portion of Americans from accessing treatment.

StAccording to some research, the promotional costs incurred by pharmaceutical companies for advertising their prescription-strength products, it is worth approximately $4.5 billion annually. Furthermore, recent estimates speak of an increase of approximately 30% in these costs in the last year alone. Currently, advertising communication on ethical drugs is prohibited in most countries, with the only exceptions (among the more advanced countries) of the USA and New Zealand.